Neuro42 is developing and commercializing advanced MRI technology for diagnosis and image-guided interventions.
Neuro42 is developing and commercializing advanced MRI technology for diagnosis and image-guided interventions.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jul 27, 2021 | Series A | $6.50M | 4 |
Zepp
|
— | Detail |
| Jan 1, 2021 | Seed | $1.30M | — | — | — | Detail |
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Zepp
|
Yes | Series A |
|
|
— | Series A |
|
|
— | Series A |
Shangbay Capital
|
— | Series A |